menu search

Abbott's (abt) cardiomems favors heart failure management

Abbott (ABT) announces key findings from meta-analysis, which shows remote pressure monitoring to be a life-extending option among heart failure patie...

March 27, 2023, 9:11 am

4 toxic stocks that you should eliminate from your portfolio

Similar to identifying stocks with growth potential, pinpointing toxic stocks and discarding them at th...

March 27, 2023, 9:11 am

Don't wait for your dividends. here's how you can collect cash every month.

cardinal Health's healthcare operations make it resilient as it generates billions in free cash flow. G...

March 22, 2023, 9:15 am

cardiovascular systems (csii) ails from soft volume, macro woes

Tough competition and consistent net loss continue to pose threats to cardiovascular Systems (CSII)....

March 20, 2023, 11:28 am

Esperion (espr) plummets 54% over milestone payment row

An SEC filing by Esperion (ESPR) reveals that partner Daiichi Sankyo disagrees with the company's assessment that ...

March 17, 2023, 2:31 pm

Cvrx reiterates plans to discuss the preliminary results from the post-market phase of the beat-hf trial at tht 2023 and schedules a conference call

MINNEAPOLIS, March 16, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturin...

March 16, 2023, 8:30 am

Here is what to know beyond why cardinal health, inc. (cah) is a trending stock

cardinal (CAH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth explo...

March 14, 2023, 10:44 am

Silence therapeutics: breaking the silence on an under-the-radar mid-stage sirna platform

Silence Therapeutics is an underfollowed British siRNA company focusing on cardiovascular and autoimmun...

March 13, 2023, 11:58 pm

Newamsterdam: an underfollowed dutch biotech cardiovascular biotech

NewAmsterdam Pharma is a Dutch SMID cap biotech focusing on cardiovascular diseases. NewAmsterdam Pharm...

March 13, 2023, 3:50 am

Pope francis’ health after 10 years in the job: slower steps, same determination

By Philip Pullella VATICAN CITY (Reuters) – Ten years ago when he became the first pope from Latin America, the former ...

March 10, 2023, 3:21 pm

Esperion therapeutics (espr) down 24% in a week: here's why

Shares of Esperion Therapeutics (ESPR) fell last week as the company's cardiovascular outcome CLEAR stu...

March 10, 2023, 12:15 pm

Fda approves respiree’s cardio-respiratory wearable

The RS001 device – developed by Singapore digital health company Respiree – measures heart rate and respiration directly and in real-time, and acc...

March 10, 2023, 8:44 am

Acutus medical to announce fourth quarter and full year 2022 financial results

CARLSBAD, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on i...

March 9, 2023, 4:01 pm

cardinal health's (cah) new tie-up to boost patient outcomes

cardinal Health's (CAH) latest partnership is expected to improve patients' healthcare journey by offer...

March 8, 2023, 1:33 pm

The global stethoscope industry is forecasted for sales volume growth reaching us$ 1056 million by 2033 | future market insights, inc.

Growing Frequency of Respiratory and cardiovascular Conditions May Help Accelerate Market Growth. Steth...

March 7, 2023, 4:30 pm

3 reasons growth investors will love cardinal (cah)

cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market....

March 7, 2023, 2:17 pm

cardiol therapeutics says new study results highlight the cardioprotective effects of cannabidiol

cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) said that new study results have demonstrated the ...

March 7, 2023, 12:22 pm

Reviva pharmaceuticals to present at the 35th annual roth conference

CUPERTINO, Calif., March 07, 2023 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clin...

March 7, 2023, 8:00 am

Stem cell therapy market size worth usd 92.08 million by 2030 at 16.20% cagr – report by market research future (mrfr)

Stem Cell Therapy Market Growth, Trends and Size Analysis by Cell Source (Adipose Tissue, Bone Marrow, Neural, Embryo/Cord, IPSCs, and PPSCs), by Type...

March 6, 2023, 2:45 pm

Are investors undervaluing cardinal health (cah) right now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe...

March 6, 2023, 11:17 am


Search within

Pages Search Results: